Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among patients with heart failure who have mitral regurgitation due to left ventricular dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve their clinical outcomes. METHODS: At 78 sites in the United States and Canada, we enrolled patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy. Patients were randomly assigned to transcatheter mitral-valve repair plus medical therapy (device group) or medical therapy alone (control group). The primary effectiveness end point was all hospitalizations for heart failure within 24 months of follow-up. The primary safety end point was freedom from device-related complications at 12 months; the rate for this end point was compared with a prespecified objective performance goal of 88.0%. RESULTS: Of the 614 patients who were enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of all hospitalizations for heart failure within 24 months was 35.8% per patient-year in the device group as compared with 67.9% per patient-year in the control group (hazard ratio, 0.53; 95% confidence interval [CI], 0.40 to 0.70; P<0.001). The rate of freedom from device-related complications at 12 months was 96.6% (lower 95% confidence limit, 94.8%; P<0.001 for comparison with the performance goal). Death from any cause within 24 months occurred in 29.1% of the patients in the device group as compared with 46.1% in the control group (hazard ratio, 0.62; 95% CI, 0.46 to 0.82; P<0.001). CONCLUSIONS: Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy, transcatheter mitral-valve repair resulted in a lower rate of hospitalization for heart failure and lower all-cause mortality within 24 months of follow-up than medical therapy alone. The rate of freedom from device-related complications exceeded a prespecified safety threshold. (Funded by Abbott; COAPT ClinicalTrials.gov number, NCT01626079 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of the tirzepatide-mediated improvement in the win ratio was large and similar to the effect of transcatheter mitral valve repair in patients with HF and secondary mitral regurgitation.32”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Self-citationPercutaneous Repair or Surgery for Mitral Regurgitation
Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., Smalling, R. W., Siegel, R., Rose, G. A., Engeron, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009355 · Cited by 2,183
Self-citationThe prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Self-citationPercutaneous Mitral Valve Interventions in the Real World
Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., Ussia, G. P., Sievert, H., Richardt, G., Widder, J. D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.094 · Cited by 839
Stone, G. W., Adams, D. H., Abraham, W. T., Kappetein, A. P., Généreux, P., Vranckx, P., Mehran, R., Kuck, K.-H., Leon, M. B., Piazza, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.049 · Cited by 594
Self-citationSecondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Self-citation
Research works printed but not linked: 1
- 16. cancer events. Biostatistics 2007; 8: 70821.
Cited by
Items 501–600 of 1,001
MitraClip and Tertiary Mitral Regurgitation—Mitral Regurgitation Gets Curiouser and Curiouser
Carabello, B. A. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0195 · Cited by 24
Doenst, T., Bargenda, S., Kirov, H., Moschovas, A., Tkebuchava, S., Safarov, R., Diab, M., & Färber, G. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01470-6 · Cited by 24
Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation
Saxon, J. T., Cohen, D. J., Chhatriwalla, A. K., Kotinkaduwa, L. N., Kar, S., Lim, D. S., Abraham, W. T., Lindenfeld, J. M., Mack, M. J., Arnold, S. V., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.09.023 · Cited by 24
Self-citationIsmayl, M., Abbasi, M. A., Al-Abcha, A. K., El-Am, E. A., Walters, R. W., Goldsweig, A. M., Alkhouli, M. A., Guerrero, M. E., & Anavekar, N. S. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028999 · Cited by 24
Ludwig, S., Conradi, L., Cohen, D. J., Coisne, A., Scotti, A., Abraham, W. T., Ali, W. B., Zhou, Z., Li, Y., Kar, S., et al. (2023) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.123.013045 · Cited by 24
“These findings are in contrast with those seen with mitral TEER in the COAPT trial and may reflect several factors (3).”
Self-citationy, A. J.-R., Freixa, X., Cid, B., Cruz‐González, I., Cebada, F. S., Baz, J. A., Lozano, Í., Sabaté, M., Jiménez, J., García, L. A. Í., et al. (2023) · Revista Española de Cardiología · doi:10.1016/j.recesp.2023.07.014 · Cited by 24
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation
Chhatriwalla, A. K., Cohen, D. J., Vemulapalli, S., Vekstein, A. M., Huded, C. P., Gallup, D. S., Kosinski, A. S., Brothers, L., Lindenfeld, J. M., Stone, G. W., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.11.012 · Cited by 24
Self-citationAnker, S. D., Friede, T., von Bardeleben, R. S., Butler, J., Fatima, K., Diek, M., Heinrich, J., Hasenfuss, G. P., Schillinger, W., & Ponikowski, P. P. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3247 · Cited by 24
Reddy, Y. N. V., Borlaug, B. A., O’Connor, C. M., & Gersh, B. J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz364 · Cited by 24
The Forgotten, Not Studied or Not Valorized Tricuspid Valve: The Transcatheter Revolution Is Coming
de Oliveira, D. C., & de Oliveira, C. G. C. (2019) · Cardiology Research · doi:10.14740/cr874 · Cited by 24
Badhwar, V., Sorajja, P., Duncan, A., Thourani, V. H., Schäfer, U., Grayburn, P. A., Dumonteil, N., Babaliaros, V. C., Garatti, A., Leipsic, J. A., et al. (2019) · EuroIntervention · doi:10.4244/eij-d-19-00333 · Cited by 24
Self-citationSlavin, S. D., & Warraich, H. J. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.07.028 · Cited by 24
Structural Heart Disease Emergencies
Jentzer, J. C., Ternus, B. W., Eleid, M. F., & Rihal, C. S. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620918776 · Cited by 24
Left Ventricular Volume Reduction and Reshaping as a Treatment Option for Heart Failure
Brener, M. I., Uriel, N. Y., & Burkhoff, D. (2020) · Structural Heart · doi:10.1080/24748706.2020.1777359 · Cited by 24
How to shape the future of cardiology and cardiac surgery?
Dreyfus, G., & Windecker, S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa707 · Cited by 24
Importance of Myocardial Fibrosis in Functional Mitral Regurgitation
Lopes, B. B. C., Kwon, D. H., Shah, D. J., Lesser, J. R., Bapat, V., Enriquez-Sarano, M. L., Sorajja, P., & Cavalcante, J. L. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.10.027 · Cited by 24
Haberman, D., Estévez‐Loureiro, R., Benito‐González, T., Denti, P., Arzamendi, D., Adamo, M., Freixa, X., y, L. N.-F., Villablanca, P. A., Krivoshei, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091819 · Cited by 24
Sex differences in outcomes of transcatheter edge‐to‐edge repair with MitraClip: A meta‐analysis
Ya’qoub, L., Gad, M. M., Faza, N. N., Kunkel, K. J., Ya’acoub, R., Villablanca, P. A., Bagur, R., Alasnag, M. A., Eng, M. H., & Elgendy, I. Y. (2022) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30110 · Cited by 24
Wybraniec, M. T., Orszulak, M., Męcka, K., & Mizia‐Stec, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114400 · Cited by 25
“There is dispute over the role of transcatheter edge-to-edge repair of the mitral valve in the treatment of fMR given the conflicting results of the MITRA-FR and COAPT trials [85,86].”
ResultChitturi, K. R., Faza, N. N., Little, S. H., Kleiman, N. S., Reardon, M. J., & Goel, S. S. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.05.030 · Cited by 23
“Patients with severe MR and cardiogenic shock were excluded from prior randomized controlled trials of transcatheter MV repair with MitraClip [3,4].”
BackgroundVolterrani, M., Hálasz, G., Adamopoulos, S. N., Agostoni, P., Butler, J., Coats, A. J. S., Solal, A. C., Doehner, W., Filippatos, G., Jankowska, E. A., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3440 · Cited by 24
A pathoanatomic approach to secondary functional mitral regurgitation: Evaluating the evidence
Badhwar, V., Alkhouli, M. A., Mack, M. J., Thourani, V. H., & Ailawadi, G. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.12.102 · Cited by 23
“Transcatheter repair will clearly have an expanding role in SMR, but successes in some patients and failures in others highlight the need for clarity in how to identify the ideal patients to receive optimal benefit from this modality.(1,2,8-10) Transcatheter MV replacement is undergoing active investigation, but anato…”
BackgroundSelf-citationFlukes, S., Sharma, R. K., Lohia, S., & Cohen, M. A. (2021) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0040-1721823 · Cited by 23
Point‐of‐care ultrasound: Closing guideline gaps in screening for valvular heart disease
Hammadah, M., Ponce, C., Sorajja, P., Cavalcante, J. L., García, S., & Gössl, M. (2020) · Clinical Cardiology · doi:10.1002/clc.23499 · Cited by 23
Guide to functional mitral regurgitation: a contemporary review
Vajapey, R. S., & Kwon, D. H. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-277 · Cited by 23
Extramitral Valvular Cardiac Involvement in Patients With Significant Secondary Mitral Regurgitation
Singh, G. K., Namazi, F., Hirasawa, K., van der Bijl, P., van Wijngaarden, A. L., Vo, N. M., Stone, G. W., Marsan, N. A., Delgado, V., & Bax, J. J. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.09.022 · Cited by 23
Self-citationde la SEC, G. D. T. D. L. S. P. L. G. E. 2. S. E. D. Y. T. D. L. I. C. A. Y. C. Y. C. D. G. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.012 · Cited by 24
Endpoints in Heart Failure Drug Development
Hussain, A., Misra, A., & Bozkurt, B. (2022) · Cardiac failure review · doi:10.15420/cfr.2021.13 · Cited by 23
Wollborn, J., Schüler, A., Sheu, R. D., Shook, D. C., & Nyman, C. B. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.11.011 · Cited by 23
Pio, S. M., Medvedofsky, D. A., Stassen, J., Delgado, V., Namazi, F., Weissman, N. J., Grayburn, P. A., Kar, S., Lim, D. S., Zhou, Z., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029956 · Cited by 23
“8 However, mortality and HFH rates remained high in the COAPT trial, even after TEER.”
Self-citationBapat, V., Weiss, E. S., BAJWA, T. K., Thourani, V. H., Yadav, P., Thaden, J. J., Lim, D. S., Reardon, M. J., Pinney, S., Adams, D. H., et al. (2024) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2024.02.033 · Cited by 24
Self-citationTrends in Mortality After Incident Hospitalization for Heart Failure Among Medicare Beneficiaries
Vohra, A. S., Moghtaderi, A., Luo, Q., Magid, D. J., Black, B. S., Masoudi, F. A., & Kini, V. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.28964 · Cited by 23
Dimitriadis, K. S., Σουλαϊδόπουλος, Σ., Pyrpyris, N., Sagris, Μ., Aznaouridis, K. A., Beneki, E., Theofilis, P., Tsioufis, P., Tatakis, F., Fragoulis, C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.034932 · Cited by 23
“1,41 In the acute phase, TEER aims to reduce MR, leading to a decrease of the left atrial pressure, pulmonary artery pressure, and LV volume overload, as well as an increase of the cardiac output, resulting in an acute improvement of hemodynamics.”
Oğuz, D., Eleid, M. F., Dhesi, S., Pislaru, S. V., Mankad, S. V., Malouf, J. F., Nkomo, V. T., Oh, J. K., Holmes, D. R., Reeder, G. S., et al. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2019.06.014 · Cited by 23
Szarek, M. J., Steg, P. G., DiCenso, D., Bhatt, D. L., Bittner, V., Budaj, A., Díaz, R., Goodman, S. G., Gotcheva, N. N., Jukema, J. W., et al. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.005858 · Cited by 23
Heart team approach in treatment of mitral regurgitation: patient selection and outcome
Külling, M., Corti, R., Noll, G., Kuest, S. M., Hürlimann, D., Wyss, C. A., Reho, I., Tanner, F. C., Külling, J., Meinshausen, N., et al. (2020) · Open Heart · doi:10.1136/openhrt-2020-001280 · Cited by 23
Percutaneous Interventions for Secondary Mitral Regurgitation
Ali, M., Shreenivas, S., Pratt, D. N., Lynch, D., & Kereiakes, D. J. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.008998 · Cited by 23
Hirasawa, K., Namazi, F., Pio, S. M., Vo, N. M., Marsan, N. A., Bax, J. J., & Delgado, V. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.08.019 · Cited by 23
Schäfer, M., Körber, M. I., Vimalathasan, R., Mauri, V., Iliadis, C., Metze, C., ten Freyhaus, H., Baldus, S. E., Polidori, M. C., & Pfister, R. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.007624 · Cited by 23
“Death within 30 d after procedure 8 (4) 1 (1) 7 (7) 0.”
InfluentialHerzinsuffizienzleitlinien 2021 der ESC
Bauersachs, J. K., & Soltani, S. (2021) · Herz · doi:10.1007/s00059-021-05084-5 · Cited by 23
“fikanten Reduktion der Hospitalisierungen und derMortalität führt [32], sodass dieser Eingriff bei symptomatischen Patienten unter optimalermedikamentöser Therapie erwogen werden sollte (Klasse IIa/B).”
BackgroundKovach, C. P., Bell, S. M., Kataruka, A., Reisman, M., & Don, C. W. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29084 · Cited by 23
Volterrani, M., Hálasz, G., Adamopoulos, S. N., Agostoni, P., Butler, J., Coats, A. J. S., Solal, A. C., Doehner, W., Filippatos, G., Jankowska, E. A., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad400 · Cited by 22
Rottländer, D., Golabkesh, M., Degen, H., Ögütcü, A., Saal, M., & Haude, M. (2022) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30157 · Cited by 22
“Besides the Carillon device, several catheter‐based techniques were developed to treat vFMR.(11,17) In the COAPT trial, vFMR reduction using MitraClip in 614 patients showed a significantly reduced rate of all‐cause mortality and hospitalization due to HF compared to medical therapy alone.”
BackgroundMethodShuvy, M., von Bardeleben, R. S., Grasso, C., Raake, P. W. J., Lurz, P. C., Zamorano, J. L., Asch, F. M., Kar, S., Maisano, F., & EXPAND Investigators (2023) · ESC Heart Failure · doi:10.1002/ehf2.14273 · Cited by 22
Self-citationAdamo, M., Rubbio, A. P., Zaccone, G., Pighi, M., Massussi, M., Tomasoni, D., Pancaldi, E., Testa, L., Tusa, M. B., MARCO, F. D., et al. (2023) · EuroIntervention · doi:10.4244/eij-d-22-00992 · Cited by 22
Park, S. M., Lee, S. Y., Jung, M., Youn, J., Kim, D., Cho, J. Y., Cho, D., Hyun, J., Cho, H., Park, S., et al. (2023) · International Journal of Heart Failure · doi:10.36628/ijhf.2023.0016 · Cited by 22
Valvular heart disease and cardiomyopathy: reappraisal of their interplay
Marsan, N. A., Graziani, F., Meucci, M. C., Wu, H. W., Lillo, R., Bax, J. J., Burzotta, F., Massetti, M., Jukema, J. W., & Crea, F. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00911-0 · Cited by 22
“According to this approach, patients with a COAPT-like phenotype of disproportionate mitral regurgitation, characterized by a greater severity of mitral regurgitation in relation to LV remodelling, might have higher chances of benefit from the mitral valve treatment than patients with a MITRA-FR-like phenotype of pro-…”
InfluentialClinical manifestations, diagnosis, and treatment of ischemic mitral regurgitation: a review
Báez‐Ferrer, N., Izquierdo‐Gómez, M. M., Marí‐López, B., Montoto-López, J., Duque, A., García‐Niebla, J., Miranda-Bacallado, J., Hernández, A. D. L. R., Laynez‐Cerdeña, I., & Lacalzada-Almeida, J. B. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.10.64 · Cited by 22
Transcatheter Mitral Valve Replacement with Intrepid
McCarthy, P. M., Kislitsina, O. N., Malaisrie, S. C., & Davidson, C. J. (2019) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2019.02.002 · Cited by 22
Shah, S., Raj, V., Abdelghany, M., Mena‐Hurtado, C., Riaz, S., Patel, S., Wiener, H. W., & Chaudhuri, D. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10051-z · Cited by 22
Das, B. B., Moskowitz, W. B., & Butler, J. (2021) · Children · doi:10.3390/children8050322 · Cited by 22
Sparrow, R. T., Sanjoy, S. S., Lindman, B. R., Tang, G. H. L., Kaneko, T., Wasfy, J. H., Pershad, A., Villablanca, P. A., Guerrero, M. E., Alraies, M. C., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.09.037 · Cited by 22
Geisler, T., Jorbenadze, R., Popov, A., Mueller, K. L., Rath, D., Droppa, M., Schreieck, J., Seizer, P., Storey, R. F., Kristensen, S. D., et al. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1694751 · Cited by 22
Kalbacher, D., Tigges, E. P., Boekstegers, P., Puls, M., Plicht, B., Eggebrecht, H., Nickenig, G., von Bardeleben, R. S., Zuern, C. S., Franke, J., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2019.12.022 · Cited by 22
Dapagliflozin Effect On Functional Mitral Regurgitation and Myocardial Remodelling: The DEFORM Trial
Huang, Z., Fan, R., Zhang, S., Zhong, J., Huang, Y., Xie, P., Yin, S., Ye, X., Xu, X., Huang, R., et al. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15296 · Cited by 21
“22 The COAPT trial 23,24 and RESHAPE-HF2 trial 25 demonstrated that TEER could reduce HF hospitalizations and mortality in FMR patients.”
Kaneko, T., Kagiyama, N., Okazaki, S., Amano, M., Satô, Y., Ohno, Y., Obokata, M., Sato, K., Morita, K., Kubo, S., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf511 · Cited by 21
“12,13 However, AFMR and VFMR differ fundamentally in their underlying mechanisms, suggesting potentially distinct optimal treatment strategies.”
InfluentialTricuspid-Valve Intervention in Heart Failure
Hausleiter, J., Stocker, T. J., Geisler, T., Lurz, P. C., Rottbauer, W., Lubos, E., Schofer, N., Frerker, C., Frank, J., Thiele, H., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2606934 · Cited by 21
Recent advances in understanding and managing mitral valve disease
Tsang, W. (2019) · F1000Research · doi:10.12688/f1000research.16066.1 · Cited by 21
“There has been great anticipation for the publication of two trials—MITRA-FR and COAPT—which have studied the utility of MitraClip in patients with symptomatic severe functional mitral regurgitation 63,64 .”
Xu, D., McBride, E., Kalra, K., Wong, K., Guyton, R. A., Sarin, E. L., & Padala, M. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.09.141 · Cited by 21
“However, recent non-annular approaches for IMR correction that did not use an annuloplasty ring, demonstrated significant improvement in cardiac function 8 .”
MethodCost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation
Cohen, D. J., Wang, K., Magnuson, E. A., Smith, R., Petrie, M. C., Buch, M. H., Abraham, W. T., Lindenfeld, J. M., Mack, M. J., Stone, G. W., et al. (2022) · Heart · doi:10.1136/heartjnl-2021-320005 · Cited by 21
Self-citationRusso, G., Maisano, F., Massaro, G., Terlizzese, G., Mariano, E. G., Bonanni, M., Matteucci, A., Bezzeccheri, A., Benedetto, D., Chiricolo, G., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.738756 · Cited by 21
“Based on the current available data, TMVI is going to enrich the MV therapy toolbox and to play a complementary role with TEER.”
BackgroundInfluentialSato, H., Cavalcante, J. L., Bae, R. Y., Bapat, V., Garcia, S. A., Gössl, M., Hashimoto, G., Fukui, M., Enriquez-Sarano, M. L., & Sorajja, P. (2022) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.121.011562 · Cited by 21
Racial Disparities in Access to High-Volume Mitral Valve Transcatheter Edge-to-Edge Repair Centers
Steitieh, D., Zaidi, A., Xu, S., Cheung, J. W., Feldman, D. N., Reisman, M., Mallya, S., Paul, T. K., Singh, H. S., Bergman, G. W., et al. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100398 · Cited by 21
Ueyama, H. A., Kuno, T., Takagi, H., Krishnamoorthy, P. M., Prandi, F. R., Palazzuoli, A., Sharma, S. K., Kini, A. S., & Lerakis, S. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10265-3 · Cited by 21
Contemporary Anatomic Criteria and Clinical Outcomes With Transcatheter Mitral Repair
Sorajja, P., Sato, H., Bapat, V., Cavalcante, J. L., Bae, R. Y., Fukui, M., Stanberry, L. I., & Enriquez-Sarano, M. L. (2023) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.122.012486 · Cited by 21
Mitral Regurgitation in Female Patients: Sex Differences and Disparities
Ocher, R., May, M. B., Labin, J. E., Shah, J., Horwich, T. B., Watson, K. E., Yang, E. H., & Press, M. C. (2023) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2023.101032 · Cited by 21
“58,61 Overall, the existing research regarding sex-based differences in percutaneous treatment of SMR is generally promising.”
BackgroundMethodResultInfluentialLiu, H., Simonian, N. T., Pouch, A. M., Iaizzo, P. A., Gorman, J. H., Gorman, R. C., & Sacks, M. S. (2023) · Journal of Biomechanical Engineering · doi:10.1115/1.4062849 · Cited by 21
Varshney, A. S., Shah, M. A., Vemulapalli, S., Kosinski, A. S., Bhatt, A. S., Sandhu, A. T., Hirji, S. A., DeFilippis, E. M., Shah, P. B., Fiuzat, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad584 · Cited by 21
Ryan, M., Ezad, S. M., Webb, I. G., O’Kane, P. D., Dodd, M., Evans, R., Laidlaw, L., Khan, S. Q., Weerackody, R. P., Bagnall, A. J., et al. (2024) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.123.013367 · Cited by 21
“49,50 Based on simulations (examples of which are shown in Table S5), we estimate that ≈ 65% of patients in the con-trol arm would experience a hierarchical outcome event.”
Structural Cardiac Interventions in Patients With Heart Failure
Hahn, R. T., Lindenfeld, J., Lim, S. D., Mack, M. J., & Burkhoff, D. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.061 · Cited by 22
Self-citationHaberman, D., Estévez‐Loureiro, R., Czarnecki, A., Melillo, F., Adamo, M., Villablanca, P. A., Sudarsky, D., Praz, F., Perl, L., Freixa, X., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3582 · Cited by 21
Metra, M., Tomasoni, D., Adamo, M., Anker, S. D., Bayés‐Genís, A., von Bardeleben, R. S., Böhm, M., Donal, E., Filippatos, G. S., Maisano, F., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.070411 · Cited by 21
A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis
Kreußer, M. M., Volz, M. J., Knop, B., Ehlermann, P., Schmack, B., Ruhparwar, A., Hegenbart, U., Schönland, S. O., Katus, H. A., & Raake, P. W. J. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01559-y · Cited by 21
Left ventricular function after correction of mitral regurgitation: Impact of the clipping approach
Hubert, A., Galli, E., Leurent, G., Corbineau, H., Bidaut, A., L'Official, G., Leclercq, C., & Donal, E. (2019) · Echocardiography · doi:10.1111/echo.14523 · Cited by 21
Elbadawi, A., Elzeneini, M., Thakker, R. A., Mahmoud, K., Elgendy, I. Y., Megaly, M. S., Hamed, M., Omer, M. A., Chowdhury, M., Ogunbayo, G. O., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.013 · Cited by 21
Ruf, T. F., Kreidel, F., Tamm, A., Geyer, M., Hahad, O., Zirbs, J., Schwidtal, B. L., Beiras-Fernández, A., Witte, K. K., Münzel, T. F., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12710 · Cited by 21
“a sound alternative to cardiac surgery in high-risk patients with severe mitral regurgitation,(5,6) with one recent edge-toedge therapy recently associated with a reduction of mortality following successful treatment.(7)”
BackgroundInfluentialGeyer, M., Keller, K., Born, S., Bachmann, K., Tamm, A., Ruf, T. F., Kreidel, F., Hahad, O., Ahoopai, M., Hobohm, L., et al. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29068 · Cited by 21
Mortality Due to Mitral Regurgitation Among Adults in the United States: 1999-2018
Parcha, V., Patel, N., Kalra, R., Suri, S. S., Arora, G., & Arora, P. K. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.08.039 · Cited by 21
Sabouret, P. F., Attias, D., Beauvais, C., Berthelot, E., Bouleti, C., Gibault‐Genty, G., Galat, A., Hanon, O., Hulot, J., Isnard, R., et al. (2021) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2021.05.004 · Cited by 21
Caiffa, T., Luca, A. D., Biagini, E., Lupi, L., Bedogni, F., Castrichini, M., Compagnone, M., Tusa, M. B., Berardini, A., Merlo, M., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2316 · Cited by 21
Reid, A. B., Zekry, S. B., Naoum, C., Takagi, H., Thompson, C., Marcelo Godoy, Z., Anastasius, M. O., Tarazi, S., Turaga, M., Boone, R. H., et al. (2022) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2022.02.008 · Cited by 21
Henry, M. P., Cotella, J. I., Mor‐Avi, V., Addetia, K., Miyoshi, T., Schreckenberg, M., Blankenhagen, M., Hitschrich, N., Amuthan, V., Citro, R., et al. (2022) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2022.02.010 · Cited by 21
Waechter, C., Ausbuettel, F., Chatzis, G., Cheko, J., Fischer, D., NEF, H. M., Barth, S., Halbfaß, P., Deneke, T., Mueller, J., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9110366 · Cited by 21
Marmagkiolis, K., Hakeem, A., Ebersole, D. G., Iliescu, C., Ateş, İ., & Çilingiroğlu, M. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28203 · Cited by 21
Mitral regurgitation worsens cardiac remodeling in ischemic cardiomyopathy in an experimental model
Onohara, D., Corporan, D., Hernandez-Merlo, R., Guyton, R. A., & Padala, M. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.06.109 · Cited by 21
Fusion imaging for transcatheter mitral and tricuspid interventions
Pascual, I., Pozzoli, A., Taramasso, M., Maisano, F., & Ho, E. C. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.169 · Cited by 21
Kavsur, R., Spieker, M., Iliadis, C., Metze, C., Transier, M., Tiyerili, V., Horn, P., Baldus, S. E., Kelm, M., Nickenig, G., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019548 · Cited by 20
Sex Differences in Prognosis of Significant Secondary Mitral Regurgitation
Namazi, F., van der Bijl, P., Vo, N. M., van Wijngaarden, S. E., Marsan, N. A., Delgado, V., & Bax, J. J. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13503 · Cited by 20
Right Ventricular Dysfunction and Tricuspid Regurgitation in Functional Mitral Regurgitation
Truong, V. T., Ngo, T. N. M., Mazur, J., Nguyen, H. T. M., Pham, T. T. M., Palmer, C., Pham, K., Phan, H., Lee, K. S. S., Bannehr, M., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13558 · Cited by 20
y, A. J.-R., Freixa, X., Cid, B., Cruz‐González, I., Cebada, F. S., Baz, J. A., Lozano, Í., Sabaté, M., Jiménez, J., García, L. A. Í., et al. (2023) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2023.07.012 · Cited by 20
Prognostic role of mitral regurgitation in patients with advanced heart failure
Pagnesi, M., Calì, F., Chiarito, M., Stolfo, D., Baldetti, L., Lombardi, C., Tomasoni, D., Loiacono, F., Maccallini, M., Villaschi, A., et al. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.11.002 · Cited by 20
Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal
Manzi, L., Buongiorno, F., Narciso, V., Florimonte, D., Forzano, I., Castiello, D. S., Sperandeo, L., Paolillo, R., Verde, N., Spinelli, A. M., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15050540 · Cited by 20
Natural history of bivalvular functional regurgitation
Bartko, P. E., Arfsten, H., Heitzinger, G., Pávó, N., Winter, M., Toma, A., Strunk, G., Hengstenberg, C., Hülsmann, M., & Goliasch, G. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey178 · Cited by 20
Ammirati, E., Heyning, C. M. V. D., Musca, F., Brambatti, M., Perna, E., Cipriani, M., Cannata, A., Mondino, M. G., Moreo, A. M., Bock, D. D., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.039 · Cited by 20
Transcatheter Mitral Valve Replacement: An Update on the Current Literature
Hajj, S. C. E., & Eleid, M. F. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0734-3 · Cited by 20
Luca, A. D., Stolfo, D., Caiffa, T., Korcova, R., Barbati, G., Vitrella, G., Rakar, S., Perkan, A., Secoli, G., Pinamonti, B., et al. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2019.07.006 · Cited by 20
Besler, C., Noack, T., von Roeder, M., Kitamura, M., Kresoja, K., Forner, A. F., Bevilacqua, C., Desch, S., Ender, J. K., Borger, M. A., et al. (2020) · EuroIntervention · doi:10.4244/eij-d-20-00216 · Cited by 20
Rupture of Papillary Muscle and Chordae Tendinae Complicating STEMI: A Call for Action
Pahuja, M., Ranka, S., Chauhan, K., Patel, A., Chehab, O., Elmoghrabi, A., Mony, S., Ando, T., Mishra, T., Singh, M., et al. (2020) · ASAIO Journal · doi:10.1097/mat.0000000000001299 · Cited by 20
Verbeke, J., Calle, S., Kamoen, V., Buyzere, M. D., & Timmermans, F. (2021) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-021-02474-y · Cited by 20
“Therefore, the use of GLS or GWI as LV systolic performance parameters in clinical practice warrants further investigation in large randomized trials [1, 2].”
MethodNoly, P., Pagani, F. D., Obadia, J., Bouchard, D., Bolling, S. F., Ailawadi, G., & Tang, P. C. Y. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2303087 · Cited by 20
“…though the natural history and pathophysiology of SMR is well appreciated, the controversy surrounding the conflicting results between (MITRA.FR [66,68] and COAPT [67,78]) provide a great opportunity to better understand the physiopathology of SMR, patient selection and outcome with intervention.”
Result
Metadata
- Authors
- Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Marx, S. O., Cohen, D. J., Weissman, N. J., & Mack, M. J.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
- University of Colorado Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-12-13
- Volume
- 379
- Issue
- 24
- Pages
- 2307-2318
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2889688444
- Cited by
- 3,017
- References
- 23
- Citations by year
- 2026: 253 · 2025: 330 · 2024: 308 · 2023: 372 · 2022: 385 · 2021: 486 · 2020: 453 · 2019: 376 · 2018: 42
- FWCI
- 256.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Surgery › Cardiac Structural Anomalies and Repair
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- transcatheter mitral valve repair, heart failure, functional mitral regurgitation, left ventricular dysfunction, heart failure hospitalization, all-cause mortality, device complications, guideline-directed medical therapy, COAPT trial, transcatheter edge-to-edge repair, mitral valve repair, transcatheter closure devices, transcatheter aortic valve implantation, transcatheter mitral valve replacement
- MeSH terms
- Aged, Aged, 80 and over, Combined Modality Therapy, Female, Heart Failure, Heart Valve Prosthesis, Hospitalization, Humans, Male, Middle Aged, Mitral Valve, Mitral Valve Insufficiency, Prosthesis Failure, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate, Intention to Treat Analysis, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.